NASDAQ: VERA

Vera Therapeutics, Inc.

Healthcare | Biotechnology

No licensed closing price on file for VERA. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Vera Therapeutics, Inc. (NASDAQ: VERA) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 13:33 UTC.

Key facts

Charts

Charts are in the appInteractive charts for VERA are available in Oxford Ledge.
Open VERA in Oxford Ledge →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-09-17

2026-09-17PRESIDENT AND CEOSale-18,500$684.5K
2026-09-17PRESIDENT AND CEOStock Option (Right to Buy)Option exercise-18,500—
2026-09-17PRESIDENT AND CEOOption exercise18,500$53.6K

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

BlackRock, Inc.5,747,760$246.64M+13.0%
Avoro Capital Advisors LLC5,723,888$245.61M-2.8%
STATE STREET CORP4,148,786$178.02M+23.3%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2026-07-09Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2021-07-14Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →

Company news

View all →

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for VERA and 5,000+ tickers.

Create a free account — keep VERA

For your agent

GET /api/data?ticker=VERA

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt